10 New 5-Star Stocks This Week
Morningstar upgraded 10 US-listed stocks to 5-star ratings, indicating undervaluation. The largest include Sanofi (SNY), LPL Financial (LPLA), Edison International (EIX), SBA Communications (SBAC), and Stellantis (STLA). The US market is moderately undervalued, with 43% of covered stocks rated undervalued.
How this was made
The 30-second read
Why it matters
The upgrades provide a shortlist of potential value plays but lack a specific catalyst beyond price decline.
Market read
A watchlist style piece with modest trading relevance; useful for value‑oriented screening.
What to watch
High uncertainty ratings for several names suggest potential downside risk despite undervaluation.
Background
Morningstar weekly screen identifies stocks whose prices have fallen into undervalued ranges, assigning 5‑star ratings.
Ticker impact
Sanofi's Morningstar rating was upgraded to 5‑stars after a 3.23% weekly loss, indicating a new undervalued signal.
potential modest upside as investors price in the 35% discount to fair value
The upgrade signals undervaluation but uncertainty is medium; price move likely limited.
LPL Financial Holdings received a 5‑star rating after a 4.18% weekly decline, marking a fresh undervalued status.
possible upward pressure as the stock trades 42% below fair value
High uncertainty rating tempers the upside potential.
Edison International was upgraded to 5‑stars following a 4.81% weekly drop, highlighting a new value opportunity.
likely modest rally given 35% discount to fair value
Medium uncertainty and regulated utility profile suggest limited volatility.
SBA Communications earned a 5‑star rating after a 6.97% weekly loss, indicating a fresh undervalued position.
potential upside as the stock sits 34% below fair value
Medium uncertainty; upside likely modest.
Stellantis was upgraded to 5‑stars after a 4.56% weekly decline, flagging a new undervalued opportunity.
possible upward move despite very high uncertainty and 54% discount
Very high uncertainty limits confidence in any price rally.
Market effects
Highlights undervalued opportunities across utilities, financial services, REITs, and automotive sectors.
Primarily U.S. market focus; European‑listed Sanofi adds a foreign component.
Limited; reflects Morningstar's rating methodology rather than macro‑economic shifts.
Counterpoint
Rating upgrades may be premature if underlying fundamentals remain weak; discounts could persist.
Key entities
- Research FirmMorningstar
Provider of the rating methodology and weekly screen.
